SDIC is a fund management company that offers financial services for scientific and technology based companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
SDIC is a fund management company that offers financial services for scientific and technology based companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2018 | Cambricon Technologies | Series B | 0 |
12/2021 | Sinomicro Medical | Series C | - |
6/2018 | SKYVERSE | Series B | 3M |
1/2023 | Ruidiwei | Series C | - |
8/2021 | Svolt Energy Technology Co., Ltd. | Series B | 0 |
12/2020 | Synlight Crystal | Series A | - |
9/2017 | OMNI | Series B | 3M |
11/2017 | OMNI | Series C | - |
5/2020 | BYD Company | Post-IPO Equity | 265M |
9/2022 | Jialichuang | Series B | 129.2M |
1/2018 | Bluetron Industrial Internet Information | Seed Round | - |
12/2021 | Jinyi New Material | Venture Round | - |
9/2016 | Twenty First Century Aerospace Technology Co., Ltd | Post-IPO Equity | 22M |
11/2022 | Grace Laser | Series C | 27.9M |
2/2019 | Intelligent Laser | Series B | 3M |
12/2022 | KM Soft | Venture Round | 29M |
12/2020 | Zhiyi Pharmaceutics | Series B | 0 |
12/2022 | Saifu Pharmaceutical | Series D | 71.2M |
7/2019 | Bai Xiniu | Angel Round | 436.5k |
6/2020 | Everbright Photonics | Series C | 21.2M |
10/2017 | ECTEK | Post-IPO Equity | 11.3M |
11/2020 | Abogen Biosciences | Series A | 0 |
12/2016 | Eucure Biopharma | Series A | 8.6M |
8/2017 | Cambricon Technologies | Series A | 100M |
12/2022 | AccuSilicon | Series F | - |
1/2021 | rivamed | Series B | - |
12/2021 | Gongda Satellite | Series A | - |
4/2022 | Yuansheng Pixel | Seed Round | - |
4/2022 | Beilai Bio | Series B | 47.1M |
9/2017 | Quadas | Series A | 1.5M |
4/2022 | Yihui Information | Series B | - |
12/2021 | MoonBiotech | Series C | 31.5M |
6/2020 | MabPlex International | Series B | 0 |
12/2019 | DTStack | Series B | - |
6/2019 | Bangsun Technology | Series C | 50.7M |
6/2022 | Dakang Medical | Series E | 0 |
1/2018 | KBP Biosciences | Series A | 0 |
2/2017 | Skyguard | Series A | 21.8M |
2/2023 | Zhishan Weixin Biotechnology | Series A | 296.6k |
11/2021 | Immunochina | Series D | - |
2/2019 | Biostar Technologies | Series B | - |
12/2021 | Time Speed | Series B | - |
4/2021 | Abogen Biosciences | Series B | 91.6M |
9/2020 | Biocytogen | Series D | 143M |
4/2018 | Biocytogen | Series C | 65.3M |
11/2019 | PhotonIC Technologies | Series C | - |
1/2023 | Spectron Technologies | Seed Round | 0 |
8/2019 | Biocytogen | Series D | 77.1M |
1/2022 | Ractigen Therapeutics | Series A | 30M |
1/2018 | YOYOSYS | Series D | 7.7M |
11/2021 | Vision Semiconductor Technology | Series A | 15.7M |
8/2022 | Viiyong | Series B | 294.6M |
10/2017 | Enmotech | Series B | 3M |
5/2021 | Huitongda | Series E | - |
10/2022 | Ningbo Testo Technology | Series A | - |
2/2018 | DigiHuman | Post-IPO Equity | 6.1M |
7/2022 | Zhiyi Pharmaceutics | Series B | 0 |
1/2023 | Yuze Semiconductor | Series B | 177.2M |
1/2023 | WITINMEM | Series B | 29.2M |
6/2018 | Changhong Intelligence | Series B | 15.3M |
11/2022 | Weishi Energy | Series B | 78.4M |
11/2022 | Vivest | Series B | - |
7/2021 | Joyo Pharma | Series B | 46.2M |
3/2018 | Bangsun Technology | Series B | 24M |
12/2016 | INVO Zhihua | Series B | 2.9M |
12/2022 | Yi Mufeng | Series A | 29M |
1/2022 | Aluksen Technology | Series B | 15.7M |
4/2022 | Weikaier Pharmaceutical Technology | Series A | - |
9/2019 | Casiris | Series D | - |
10/2022 | Xindi Digital Engineering System | Venture Round | 96.8M |
1/2019 | MabPlex International | Series A | 0 |
12/2019 | HQ Education | Series A | - |
10/2021 | Yingmai Medical | Series B | - |
12/2021 | Weishi Energy | Series A | 0 |
11/2021 | Guangdong Xinjuneng | Venture Round | - |
12/2018 | ZETTASTONE | Angel Round | 0 |
7/2017 | Eucure Biopharma | Series A | 10.3M |
9/2022 | Linkingfresh.com | Series B | - |
10/2022 | GBASE | Post-IPO Equity | - |
8/2018 | Everbright Photonics | Series B | 21.9M |
12/2019 | Remegen | Private Equity Round | - |
5/2017 | HiGo | Angel Round | 434.5k |
1/2017 | Biocytogen | Series B | - |
1/2022 | Air Touch | Series C | 15.8M |
9/2021 | Hestia Power | Series A | - |
3/2021 | Aucta Pharmaceuticals China | Series A | - |
4/2022 | Ouyeel Semiconductor | Seed Round | - |
7/2022 | Zhiyi Pharmaceutics | Series B | 0 |
6/2022 | Dakang Medical | Series E | 0 |
4/2022 | Ouyeel Semiconductor | Seed Round | - |
4/2022 | Yuansheng Pixel | Seed Round | - |
4/2022 | Weikaier Pharmaceutical Technology | Series A | - |
4/2022 | Beilai Bio | Series B | 0 |
4/2022 | Yihui Information | Series B | - |
1/2022 | Ractigen Therapeutics | Series A | 0 |
1/2022 | Air Touch | Series C | 0 |
1/2022 | Aluksen Technology | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|